# Tarpeyo

NDC: 81749-004
Generic name: budesonide
Labeler / Manufacturer: Calliditas Therapeutics AB
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20211215

FDA application: NDA215935

## Active ingredients

- BUDESONIDE: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81749-004"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81749-004
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=938cada4-d6bf-4252-836f-dd40f9eadb4d